This copper-binding tripeptide activates TGF-beta/SMAD pathway signaling, stimulates collagen I and III synthesis, upregulates TIMP-1 and TIMP-2 to protect collagen from degradation, and modulates gene expression across approximately 4,000 human genes
used 0.1 mg/kg subcutaneously in scopolamine-induced amnesia models, while traumatic brain injury research has employed higher doses up to 5.0 mg/kg
10.3389/fnagi.2021.782082 Front
Kamp-Bruls YMH, Op den Kamp YJM, Veeraiah P, Zapata Perez R, Phielix E, Havekes B, et al
Protective and therapeutic effects of Scutellaria baicalensis and its main active ingredients baicalin and baicalein against natural toxicities and physical hazards: a review of mechanisms
For users experiencing the common GI side effects of triple agonist therapy, this support can make the difference between tolerating treatment and discontinuing